Medartis Holding AG (SWX:MED)
Switzerland · Delayed Price · Currency is CHF 89.10
+1.30 (1.48%)
Aug 3, 2026, 5:30 PM CET
Medartis Holding AG Balance Sheet
Financials in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
Assets
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 32.97 | 138.69 | 25.2 | 20.61 | 82.64 |
Cash & Short-Term Investments | 32.97 | 138.69 | 25.2 | 20.61 | 82.64 |
Cash Growth | -76.23% | 450.32% | 22.30% | -75.07% | -0.11% |
Accounts Receivable | 50.34 | 41.42 | 40.48 | 39.93 | 32.5 |
Other Receivables | 8.64 | 4.8 | 5.66 | 5.43 | 3.82 |
Total Trade Receivables | 58.98 | 46.22 | 46.14 | 45.36 | 36.32 |
Inventory | 98.2 | 79.15 | 68.3 | 69.9 | 54.3 |
Other Current Assets | 5.14 | 1.89 | 1.78 | 2.01 | 2.22 |
Total Current Assets | 195.28 | 265.95 | 141.42 | 137.88 | 175.48 |
Net Property, Plant & Equipment | 94.06 | 75.95 | 80.07 | 79.28 | 64.56 |
Other Intangible Assets | 241.42 | 51.86 | 64.65 | 69.99 | 11.92 |
Long-Term Investments | 1.28 | 35.17 | 34.26 | 15.43 | 16.59 |
Other Long-Term Assets | 27.88 | 31.04 | 29.14 | 25.31 | 29.63 |
Total Assets | 559.92 | 459.96 | 349.53 | 327.89 | 298.18 |
Liabilities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 40.54 | 28.39 | 25.43 | 24.79 | 23.93 |
Accrued Expenses | 5.51 | 3.8 | 3.32 | 2.67 | 2.45 |
Current Portion of Long-Term Debt | 26.58 | 7.78 | 6.76 | 5.62 | 4.59 |
Other Current Liabilities | 15.55 | 11.04 | 10.45 | 6.45 | 3.74 |
Total Current Liabilities | 88.17 | 51.02 | 45.96 | 39.53 | 34.71 |
Long-Term Debt | 131.54 | 113.44 | 20.63 | 22.34 | 19.49 |
Other Long-Term Liabilities | 64.33 | 25.85 | 27.99 | 28.25 | 19.99 |
Total Long-Term Liabilities | 195.88 | 139.3 | 48.62 | 50.59 | 39.48 |
Total Liabilities | 284.05 | 190.32 | 94.58 | 90.11 | 74.18 |
Shareholders' Equity
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 2.73 | 2.72 | 2.47 | 2.37 | 2.36 |
Treasury Stock | -0.24 | -0.24 | - | - | - |
Additional Paid-in Capital | 293.01 | 290.5 | 288.41 | 257.65 | 254.2 |
Accumulated Other Comprehensive Income | -11.44 | -4.04 | -5.08 | 0.81 | 1.56 |
Retained Earnings | -8.18 | -19.3 | -30.84 | -23.05 | -34.13 |
Shareholders' Equity | 275.87 | 269.65 | 254.96 | 237.78 | 224 |
Total Liabilities & Equity | 559.92 | 459.96 | 349.53 | 327.89 | 298.18 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 158.12 | 121.23 | 27.39 | 27.96 | 24.07 |
Net Cash (Debt) | -125.15 | 17.46 | -2.19 | -7.35 | 58.57 |
Net Cash Growth | - | - | - | - | 5.42% |
Net Cash Per Share | -10.05 | 1.41 | -0.18 | -0.62 | 4.96 |
Book Value | 275.87 | 269.65 | 254.96 | 237.78 | 224 |
Book Value Per Share | 22.16 | 21.74 | 20.78 | 20.09 | 18.98 |
Tangible Book Value | 34.45 | 217.79 | 190.31 | 167.79 | 212.08 |
Tangible Book Value Per Share | 2.77 | 17.55 | 15.51 | 14.18 | 17.97 |